The Effect of Liposome Vitamin C on the Absorption and Metabolism of the Human Body.
NCT ID: NCT04886752
Last Updated: 2021-05-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
11 participants
INTERVENTIONAL
2019-06-10
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Vitamin C on Iron Absorption
NCT00570895
An Exploratory Investigation of a B12 Vitamin to Increase Energy and Focus
NCT05517005
Cobalamin Absorption From Fortified Food
NCT01399164
High Dose Ascorbic Acid Treatment of CMT1A
NCT00484510
Effect of Methylcobalamin and Cyanocobalamin Consumption on Vitamin B12 Nutritional Status
NCT05785585
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
vitamin C without liposome
vitamin C without liposome
vitamin C without liposome
subjects need to take 3 tests during trail. After each test was completed, a washout period of 14 days was required before the next test start
liposomal process A vitamin C
liposomal process A vitamin C
liposomal process A vitamin C
subjects need to take 3 tests during trail. After each test was completed, a washout period of 14 days was required before the next test start
liposomal process B vitamin C (Double Nutri™)
liposomal process B vitamin C (Double Nutri™)
liposomal process B vitamin C (Double Nutri™)
subjects need to take 3 tests during trail. After each test was completed, a washout period of 14 days was required before the next test start
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
vitamin C without liposome
subjects need to take 3 tests during trail. After each test was completed, a washout period of 14 days was required before the next test start
liposomal process A vitamin C
subjects need to take 3 tests during trail. After each test was completed, a washout period of 14 days was required before the next test start
liposomal process B vitamin C (Double Nutri™)
subjects need to take 3 tests during trail. After each test was completed, a washout period of 14 days was required before the next test start
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. No heart, liver, kidney, endocrine and major organic diseases
Exclusion Criteria
2. Cancer
3. Underweight (BMI≦17) or obese (BMI≧27),
4. Take chronic disease drugs,
5. Blood pressure systolic blood pressure ≧130 mmHg or diastolic blood pressure ≧85 mmHg,
6. Too high fasting blood glucose ≧ 100 mg/dL,
7. Triglyceride ≧ 150 mg/dL,Total cholesterol ≧ 200 mg/dL,
8. Have a history of vitamin C allergy,
9. People with mental illness,
10. Pregnant or breastfeeding women,
11. Hematosis,
12. Kidney stones,
13. Long-term vitamin C supplements (at least 200 mg per day for more than one month)
20 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
TCI Co., Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jaw-Shiun Tsai, Doctor
Role: PRINCIPAL_INVESTIGATOR
National Taiwan University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research & Design Center, TCI CO., Ltd
Taipei, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
201903113RSA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.